Carefully Designing De-escalation Trials in Breast Cancer medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
No Improvement in OS With Atezolizumab in Relapsing TNBC medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Early relapsing disease has again shown the limitations of immunotherapy in triple-negative breast cancer after a trial found no overall survival benefit with the drug.